89 results
Page 2 of 5
6-K
EX-99.1
amxe9e fvb
28 Nov 23
SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment
4:00pm
6-K
EX-99.1
3js2vvbm4w
18 Oct 23
Report of Foreign Private Issuer
6:54am
6-K
EX-99.2
pis53t35v i8ck9ps
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
EX-99.1
y4a w6kk2g7
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
EX-99.2
0ol 9s15ntwwapyv5d
29 Sep 23
SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split
7:46am
6-K
EX-99.1
hg2hp5l
19 Sep 23
SciSparc Engages Investment Bank to Identify Potential Strategic Transaction Opportunities
6:16pm
6-K
EX-99.1
y3cqyitp sdt
2 Aug 23
Report of Foreign Private Issuer
12:00am
6-K
EX-99.1
owiq th8ffw4i2na
30 Jun 23
SciSparc Receives Approval to Conduct Phase IIb Clinical Trial for SCI-110 to Treat Tourette Syndrome in Germany
4:10pm
6-K
EX-99.1
o1k58sv k6kewolo
2 Jun 23
SciSparc Announces Successful Final Phase IIa Results, Meeting End Points of its Phase IIa Alzheimer Disease Patients with Agitation Trial
9:04am
6-K
EX-99.1
2p8a3
2 May 23
SciSparc Completed Treatment of Last Patient Enrolled for its Phase IIa Clinical Trial for Alzheimer’s Disease and Agitation
7:28am
6-K
EX-99.2
nync35xjs t0avvyb3
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.1
bpdksvqao9
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.1
xqx ry2lkrfsem5
8 Nov 22
SciSparc Announced Positive Interim Results Meeting Primary Endpoints at Phase IIa Study in Alzheimer’s Disease Patients with Agitation
7:33am
6-K
EX-99.1
541icqj
9 Jun 22
SciSparc’s Board of Directors Provides Strategic Decision
8:38am
6-K
EX-99.1
flz3 z9hq0hl9
1 Jun 22
SciSparc to Collaborate with Polyrizon for Brain Targeting Using Intranasal Hydrogel Systems
4:11pm
6-K
EX-99.1
b20e6d07sqm3
11 May 22
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields New Patent Application for Psychedelic Combination Treatment for Binge Behaviors
1:58pm
6-K
EX-99.1
bhbapctqkm6m1m3a
1 Apr 22
SciSparc Announces Closing of New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases
6:02am
6-K
EX-99.1
b626820
10 Mar 22
SciSparc Launches New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases
10:16am